Business Segment Information (Tables)

9 Months Ended

Sep. 30, 2022

Segment Reporting [Abstract]

Schedule of Revenue, Operating Income and Total Assets by Reportable Segment

Revenue and operating income by reportable segment are presented below (in millions):

	Three Months Ended September 30,						Nine Months Ended September 30,
	2022			2021			2022			2021
Revenue:
BSI Life Science	$	383.2		$	380.7		$	1,094.3		$	1,074.3
BSI Nano		199.1			174.9			559.8			504.6
BEST		59.3			57.0			178.2			166.0
Eliminations (a)		(2.7	)		(3.7	)		(10.0	)		(10.5	)
Total revenue	$	638.9		$	608.9		$	1,822.3		$	1,734.4
Operating income (loss):
BSI Life Science	$	104.2		$	100.9		$	260.3		$	263.4
BSI Nano		35.3			21.8			72.2			55.1
BEST		8.2			7.4			21.4			18.3
Corporate, eliminations and other (b)		(16.4	)		(16.9	)		(52.2	)		(48.9	)
Total operating income	$	131.3		$	113.2		$	301.7		$	287.9

(a)Represents product and service revenue between reportable segments.

(b)Represents corporate costs and eliminations not allocated to the reportable segments.

Total assets by reportable segment are as follows (in millions):

	September 30, 2022			December 31, 2021
Assets:
BSI Life Science, BSI Nano & Corporate	$	3,254.0		$	3,560.5
BEST		89.0			97.9
Eliminations and other (a)		(6.1	)		(8.4	)
Total assets	$	3,336.9		$	3,650.0

Assets not allocated to the reportable segments and eliminations of intercompany transactions.